RecruitingNCT06548399

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

Bacterial Production of LPC and LPA and Symptoms Generation in Inflammatory Bowel Disease Patients With Chronic Abdominal Pain: a Longitudinal Exploratory Study


Sponsor

McMaster University

Enrollment

15 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to investigate whether the gut bacteria in IBD patients cause ongoing abdominal pain, even when the disease is calm. Many inflammatory bowel disease (IBD) patients have this pain, regardless of whether their disease is active or not. This might be linked to an imbalance in gut bacteria. Certain IBD patients with persistent abdominal pain experience increased sensitivity in their gut due to bacteria producing LPC and LPA. Our goal is to explore the connection between bacterial LPC/LPA levels and symptoms in IBD patients with long-lasting abdominal pain. Additionally, we aim to pinpoint the specific bacteria responsible for producing LPC/LPA, which in turn causes chronic abdominal pain in these patients.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This observational study is looking at the role of certain molecules (LPC and LPA) produced by gut bacteria in patients with inflammatory bowel disease (IBD) — either Crohn's disease or ulcerative colitis — who experience persistent abdominal pain even when their bowel inflammation appears controlled. The study aims to understand whether these bacterial molecules contribute to ongoing pain signals. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with Crohn's disease or ulcerative colitis - You have a history of moderate to severe chronic abdominal pain that persists even when your inflammation is in remission or only mildly active - Your recent imaging and lab tests confirm low-level or no active inflammation **You may NOT be eligible if...** - Your IBD is currently in a severe active flare - You have other conditions that cause abdominal pain unrelated to IBD - You are pregnant - You have had recent bowel surgery - You do not meet the specific inflammation level thresholds defined by the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

McMaster University

Hamilton, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06548399


Related Trials